ICAM1 and bronchiectasis: The matching core targets included ALB, IL10, ICAM1, and MAPK1, indicating that the effective ingredients of the herbs in this formula might physically interact with these targets.This result characterizes the unique pharmacodynamic properties of BMGLF with respect to the treatment of bronchiectasis.